- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 16/40 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies against enzymes
Patent holdings for IPC class C07K 16/40
Total number of patents in this class: 5396
10-year publication summary
|
393
|
376
|
385
|
368
|
376
|
338
|
368
|
351
|
387
|
71
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regeneron Pharmaceuticals, Inc. | 4573 |
137 |
| Genentech, Inc. | 4065 |
121 |
| Hoffmann-La Roche Inc. | 3659 |
112 |
| Omeros Corporation | 311 |
97 |
| F. Hoffmann-La Roche AG | 7847 |
90 |
| Amgen Inc. | 4335 |
86 |
| The Regents of the University of California | 20502 |
77 |
| aTyr Pharma, Inc. | 165 |
74 |
| Takeda Pharmaceutical Company Limited | 2726 |
71 |
| Pangu BioPharma Limited | 106 |
69 |
| University of Leicester | 217 |
52 |
| Novartis AG | 10420 |
43 |
| Immatics Biotechnologies GmbH | 1126 |
41 |
| Janssen Biotech, Inc. | 1659 |
41 |
| The Johns Hopkins University | 5798 |
35 |
| Dana-Farber Cancer Institute, Inc. | 2629 |
35 |
| The Trustees of the University of Pennsylvania | 4406 |
34 |
| Mayo Foundation for Medical Education and Research | 3351 |
34 |
| Kymab Limited | 266 |
34 |
| Chugai Seiyaku Kabushiki Kaisha | 1391 |
30 |
| Other owners | 4083 |